Background: Mechanical circulatory supports are used in case of cardiogenic shock (CS) refractory to conventional therapy. Several devices can be employed, but are limited by their availability, benefit risk-ratio, and/or cost.
Aims: To investigate the feasibility, safety, and effectiveness of a long-term support by a new available device (IVAC2L) in pigs.